{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T13:29:51Z","timestamp":1783344591035,"version":"3.54.6"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Scienc","doi-asserted-by":"crossref","award":["Grant Number JP16K19623"],"award-info":[{"award-number":["Grant Number JP16K19623"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Membrane Biol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00232-021-00206-w","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T16:02:36Z","timestamp":1636128156000},"page":"117-122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Sphingomyelin Phosphodiesterase Acid-Like 3b is Essential for Toll-Like Receptor 3 Signaling in Human Podocytes"],"prefix":"10.1007","volume":"255","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4379-5857","authenticated-orcid":false,"given":"Shojiro","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umetsu","family":"Hidenori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sato","family":"Riko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Aizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Tsugawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadaatsu","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,5]]},"reference":[{"key":"206_CR1","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1096\/fj.201600618R","volume":"31","author":"A Ahmad","year":"2017","unstructured":"Ahmad A, Mitrofanova A, Bielawski J, Yang Y, Marples B, Fornoni A, Zeidan YH (2017) Sphingomyelinase-like phosphodiesterase 3b mediates radiation-induced damage of renal podocytes. FASEB J 31:771\u2013780. https:\/\/doi.org\/10.1096\/fj.201600618R","journal-title":"FASEB J"},{"key":"206_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1089\/sur.2006.050","volume":"8","author":"J Cuschieri","year":"2007","unstructured":"Cuschieri J, Bulger E, Billgrin J, Garcia I, Maier RV (2007) Acid sphingomyelinase is required for lipid Raft TLR4 complex formation. Surg Infect 8:91\u2013106. https:\/\/doi.org\/10.1089\/sur.2006.050","journal-title":"Surg Infect"},{"key":"206_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1126\/scitranslmed.3002231","volume":"3","author":"A Fornoni","year":"2011","unstructured":"Fornoni A, Sageshima J, Wei C et al (2011) Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med 3:85\u201346. https:\/\/doi.org\/10.1126\/scitranslmed.3002231","journal-title":"Sci Transl Med"},{"key":"206_CR4","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1097\/01.asn.0000097371.64671.65","volume":"14","author":"GD Han","year":"2003","unstructured":"Han GD, Koike H, Nakatsue T, Suzuki K, Yoneyama H, Narumi S, Kobayashi N, Mundel P, Shimizu F, Kawachi H (2003) IFN-inducible protein-10 has a differential role in podocyte during Thy 1.1 glomerulonephritis. J Am Soc Nephrol 14:3111\u20133126. https:\/\/doi.org\/10.1097\/01.asn.0000097371.64671.65","journal-title":"J Am Soc Nephrol"},{"key":"206_CR5","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/j.celrep.2015.05.006","volume":"11","author":"LX Heinz","year":"2015","unstructured":"Heinz LX, Baumann CL, K\u00f6berlin MS et al (2015) The lipid-modifying enzyme SMPDL3B negatively regulates innate immunity. Cell Rep 11:1919\u20131928. https:\/\/doi.org\/10.1016\/j.celrep.2015.05.006","journal-title":"Cell Rep"},{"key":"206_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ceb.2016.01.010","volume":"39","author":"MS K\u00f6berlin","year":"2016","unstructured":"K\u00f6berlin MS, Heinz LX, Superti-Furga G (2016) Functional crosstalk between membrane lipids and TLR biology. Curr Opin Cell Biol 39:28\u201336. https:\/\/doi.org\/10.1016\/j.ceb.2016.01.010","journal-title":"Curr Opin Cell Biol"},{"key":"206_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.immuni.2005.12.012","volume":"24","author":"HK Lee","year":"2006","unstructured":"Lee HK, Dunzendorfer S, Soldau K, Tobias PS (2006) Double-stranded RNA-mediated TLR3 activation is enhanced by CD14. Immunity 24:153\u2013163. https:\/\/doi.org\/10.1016\/j.immuni.2005.12.012","journal-title":"Immunity"},{"key":"206_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jmb.2012.05.006","volume":"421","author":"J Luo","year":"2012","unstructured":"Luo J, Obmolova G, Malia JT et al (2012) Lateral clustering of TLR3: dsRNA signaling units revealed by TLR3ecd:3Fabs quaternary structure. J Mol Biol 421:112\u2013124. https:\/\/doi.org\/10.1016\/j.jmb.2012.05.006","journal-title":"J Mol Biol"},{"key":"206_CR9","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1038\/s41467-019-10584-4","volume":"10","author":"A Mitrofanova","year":"2019","unstructured":"Mitrofanova A, Mallela SK, Ducasa GM et al (2019) SMPDL3b modulates insulin receptor signaling in diabetic kidney disease. Nat Commun 10:2692. https:\/\/doi.org\/10.1038\/s41467-019-10584-4","journal-title":"Nat Commun"},{"key":"206_CR10","doi-asserted-by":"publisher","first-page":"158549","DOI":"10.1016\/j.bbalip.2019.158549","volume":"1865","author":"K Prymasa","year":"2020","unstructured":"Prymasa K, \u015awi\u0105tkowskaa A, Traczyka G, Ziemli\u0144ska E, Dziewulska A, Ciesielska A, Kwiatkowska K (2020) Sphingomyelin synthase activity affects TRIF-dependent signaling of Toll-like receptor 4 in cells stimulated with lipopolysaccharide. Biochim Biophys Acta Mol Cell Biol Lipids 1865:158549. https:\/\/doi.org\/10.1016\/j.bbalip.2019.158549","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"206_CR11","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1016\/j.bbamem.2015.03.014","volume":"1848","author":"JM Ruysschaert","year":"2015","unstructured":"Ruysschaert JM, Lonez C (2015) Role of lipid microdomains in TLR-mediated signaling. Biochim Biophys Acta 1848:1860\u20131867. https:\/\/doi.org\/10.1016\/j.bbamem.2015.03.014","journal-title":"Biochim Biophys Acta"},{"key":"206_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/ndt\/gfr271","volume":"27","author":"M Shimada","year":"2012","unstructured":"Shimada M, Ishimoto T, Lee PL et al (2012) Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-\u03baB-dependent pathway. Nephrol Dial Transplant 27:81\u201389. https:\/\/doi.org\/10.1093\/ndt\/gfr271","journal-title":"Nephrol Dial Transplant"},{"key":"206_CR13","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.4049\/jimmunol.1501734","volume":"196","author":"M Tatematsu","year":"2016","unstructured":"Tatematsu M, Yoshida R, Morioka Y, Ishii N, Funami K, Watanabe A, Saeki K, Seya T, Matsumoto M (2016) Raftlin controls lipopolysaccharide-induced TLR4 internalization and TICAM-1 signaling in a cell type-specific manner. J Immunol 196:3865\u20133876. https:\/\/doi.org\/10.4049\/jimmunol.1501734","journal-title":"J Immunol"},{"key":"206_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000514589","volume":"46","author":"H Umetsu","year":"2021","unstructured":"Umetsu H, Watanabe S, Imaizumi T, Aizawa T, Tsugawa K, Kawaguchi S, Seya K, Matsumiya T, Tanaka H (2021) Interleukin-6 via toll-like receptor 3 signaling attenuates the expression of proinflammatory chemokines in human podocytes. Kidney Blood Press Res 46:207\u2013218. https:\/\/doi.org\/10.1159\/000514589","journal-title":"Kidney Blood Press Res"},{"key":"206_CR15","doi-asserted-by":"publisher","first-page":"36836","DOI":"10.1074\/jbc.M110.167973","volume":"285","author":"Y Wang","year":"2010","unstructured":"Wang Y, Liu L, Davies RD, Segal MD (2010) Dimerization of toll-like receptor 3 (TLR3) is required for ligand binding. J Biol Chem 285:36836\u201336841. https:\/\/doi.org\/10.1074\/jbc.M110.167973","journal-title":"J Biol Chem"},{"key":"206_CR16","doi-asserted-by":"publisher","first-page":"10702","DOI":"10.1074\/jbc.M110.185793","volume":"286","author":"A Watanabe","year":"2011","unstructured":"Watanabe A, Tatematsu M, Saeki K, Shibata S, Shime H, Yoshimura A, Obuse C, Seya T, Matsumoto M (2011) Raftlin is involved in the nucleocapture complex to induce poly(I:C)-mediated TLR3 activation. J Biol Chem 286:10702\u201310711. https:\/\/doi.org\/10.1074\/jbc.M110.185793","journal-title":"J Biol Chem"},{"key":"206_CR17","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/ped.13355","volume":"59","author":"S Watanabe","year":"2017","unstructured":"Watanabe S, Tsugawa K, Tsuruga K, Imaizumi T, Tanaka H (2017) Urinary excretion of sphingomyelinase phosphodiesterase acid-like 3b in children with intractable nephrotic syndrome. Pediatr Int 59:1112\u20131115. https:\/\/doi.org\/10.1111\/ped.13355","journal-title":"Pediatr Int"},{"key":"206_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s10157-020-01970-0","volume":"25","author":"S Watanabe","year":"2021","unstructured":"Watanabe S, Hirono K, Aizawa T, Tsugawa K, Joh K, Imaizumi T, Tanaka H (2021) Podocyte sphingomyelin phosphodiesterase acid-like 3b decreases among children with idiopathic nephrotic syndrome. Clin Exp Nephrol 25:44\u201351. https:\/\/doi.org\/10.1007\/s10157-020-01970-0","journal-title":"Clin Exp Nephrol"},{"key":"206_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1681\/ASN.2013111213","volume":"26","author":"TH Yoo","year":"2015","unstructured":"Yoo TH, Pedigo CE, Guzman J et al (2015) Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease. J Am Soc Nephrol 26:133\u2013147. https:\/\/doi.org\/10.1681\/ASN.2013111213","journal-title":"J Am Soc Nephrol"}],"container-title":["The Journal of Membrane Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00232-021-00206-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00232-021-00206-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00232-021-00206-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T12:04:37Z","timestamp":1644667477000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00232-021-00206-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,5]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["206"],"URL":"https:\/\/doi.org\/10.1007\/s00232-021-00206-w","relation":{},"ISSN":["0022-2631","1432-1424"],"issn-type":[{"value":"0022-2631","type":"print"},{"value":"1432-1424","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,5]]},"assertion":[{"value":"10 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Shojiro Watanabe received research funding from Ono Pharmaceutical Co., Ltd, Japan. The other authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study did not involve human and animal subjects which otherwise required ethical approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}